The Effect of Motilin on the Frequency and Amount of Food Intake
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Jan 16, 2017
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI \< 30 kg/m² for lean volunteers
- • BMI \> 30 kg/m² for obese volunteers
- • Subject is capable and willing to give informed consent
- • Female volunteers of child bearing potential must use oral, injected or implanted hormonal methods of contraception
- Exclusion Criteria:
- • Female volunteer is pregnant or breastfeeding
- • GI diseases, major abdominal surgery
- • Major psychiatric illnesses
- • Volunteers that use drugs affecting the GI tract or the central nervous system
- • Volunteers suffering from endocrine diseases such as diabetes, Cushing's disease, Addison's disease, hypothalamic tumor
- • Volunteers that have undergone surgical procedure for weight loss
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jan Tack, Prof
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials